UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2020

Commission File Number: 001-39152

FSD PHARMA INC.
(Translation of registrant's name into English)

520 William Street
Cobourg, Ontario
K9A 3A5
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [  ]      Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):             


SIGNATURES

 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

FSD Pharma Inc.

 

 

(Registrant)

 

 

 

 

 

 

Date: June 9, 2020

 

By: /s/ Donal Carroll

 

 

Name: Donal Carroll

 

 

Title: Chief Financial Officer

 

 

 



EXHIBIT INDEX

Exhibit   Description
   
99.1   News release dated June 9, 2020


FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more FSD Pharma Charts.
FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more FSD Pharma Charts.